Caricamento...
Consequences of the 340B Drug Pricing Program
BACKGROUND: The 340B Drug Pricing Program entitles qualifying hospitals to discounts on outpatient drugs, increasing the profitability of drug administration. By tying the program eligibility of hospitals to their Disproportionate Share Hospital (DSH) adjustment percentage, which reflects the propor...
Salvato in:
| Pubblicato in: | N Engl J Med |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6073067/ https://ncbi.nlm.nih.gov/pubmed/29365282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMsa1706475 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|